Crossmark

MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A

Crossref DOI link: https://doi.org/10.1016/j.aohep.2021.100570

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Zhao, Wenyue

Liu, Xueping
License Information

Text and Data Mining valid from 2022-01-01

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2021-10-20
More Information

This article is maintained by: Elsevier

Article Title: MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2021.100570

Content Type: article

Copyright: © 2021 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.